GSK BLISSc-ILD 218224 Patient
com.medable.axon.cs.gsk_blissc_ild
100+
installs · ≈112
—
0 ratings
2023-04-26
first release
2024-10-21
last update
Description
This app is for registered study participants of GSK BLISSc-ILD only
This app has been created exclusively for participants in the medical study for GSK BLISSc-ILD. It contains Televisit functionality and allows participants to complete questionnaires.
A Phase 2/3, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of belimumab administered subcutaneously in adults with systemic sclerosis associated interstitial lung disease (SSc-ILD).
What's new
Bug fixes and performance improvements.
Details
| Version | 5.0.1000.03-prod |
|---|---|
| Minimum Android version | 6.0 |
| Reviews | 0 |
| Available in | Argentina, American Samoa, Australia, Åland Islands, Belgium, Bulgaria, Brazil, Canada, Germany, Denmark, Spain, Finland and 17 more |
| Developer contacts | on the Business plan |
| Collected | 2026-11-15 |
This data in the API
The full record in JSON costs 1 token.
curl -H "X-API-Key: YOUR_KEY" \ "https://apkapi.com/api/v1/app?id=com.medable.axon.cs.gsk_blissc_ild"
